Skip to main content

Animations

MJFF Publications

6291 - 6300 of 6458 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2024
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Evidence forGRNconnecting multiple neurodegenerative diseases
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcab095
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01199-2
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Temporal trajectory of biofluid markers in Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-94345-8
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.676744
    Citation Count: 23
  • Summary Details
    OPEN
    Title: An implantable human stem cell-derived tissue-engineered rostral migratory stream for directed neuronal replacement
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-021-02392-8
    Citation Count: 9
  • Summary Details
    OPEN
    Title: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-52298-2
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson’s Disease Cohorts
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-212657
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Unhealthy Behaviours and Risk of Parkinson’s Disease: A Mendelian Randomisation Study
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-202487
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Structural basis of polyamine transport by human ATP13A2 (PARK9)
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.08.017
    Citation Count: 47
  • Summary Details
    OPEN
    Title: The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.754016
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.